CALGARY, ALBERTA--(Marketwire - June 9, 2011) - Life Sciences Institute Inc. (TSX VENTURE:LSN) (the "Corporation") is pleased to announce that it has received TSX Venture Exchange ("TSXV") approval to extend the timeframe for its previously announced Short Form Offering Document financing, flow-through financing and change of business (collectively the "Transactions").
The Corporation must close the Transactions no later than July 15, 2011 and submit final documentation to the TSXV no later than July 20, 2011.
As previously announced, the financings must raise aggregate gross proceeds of at least $2,850,000 and there is no assurance that such final documentation will be submitted and TSXV approval granted.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Leonard Van Betuw
Promoter, Proposed President and Chief Executive Officer
(587) 228-7070
Life Sciences Institute Inc.
Robert C. Thomas
Current President and Chief Executive Officer
(403) 862-7463